Comprehending the Unfolded Protein Response as a Conduit for Improved Mesenchymal Stem Cell-Based Therapeutics

被引:0
|
作者
Mullick, Madhubanti [1 ,2 ]
Nayak, Sunita [1 ,2 ]
机构
[1] VIT, CBCMT, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India
[2] VIT, Ctr Biomat Cellular & Mol Theranost, Cellular & Mol Therapeut Lab, Vellore 632014, Tamil Nadu, India
关键词
Mesenchymal stem cells; Endoplasmic reticulum stress; Unfolded protein response; Reactive oxygen species; Hypoxia-reperfusion; Anoikis; ER; TRANSCRIPTION; MITOCHONDRIAL; NRF2; ACTIVATION; MECHANISMS; ISOMERASE; STRESS; IRE1;
D O I
10.1007/s40883-019-00143-0
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Endoplasmic reticulum (ER) is an intracellular organelle that contributes to efficacious protein synthesis, folding, assembly and transportation. When the normal functions of the ER are perturbed, ER stress is generated which in turn activates an unfolded protein response (UPR). UPR helps in combating this ER stress only at its threshold level, via the inhibition of protein synthesis. This is essentially mediated through increased chaperones and decreased proteins synthesis. Although when the cell undergoes continued ER-stress, UPR ultimately converges to cell-apoptosis, which leads to loss of MSCs viability. Therefore, a delineation into the molecular mechanisms of UPR would be an insightful attempt to curb the prominent loss of MSCs post-transplant. The regenerative potential of MSCs, along with their ubiquitous source of origin, offers vast opportunities with respect to the applications in diverse interdisciplinary sectors of research. But the prevalent loss of MSCs due to certain factors like reactive oxygen species (ROS), hypoxia-reperfusion (H/R), anoikis and inflammation, results in lack of persistence of transplanted MSCs. These hostile conditions contribute to an up surged endoplasmic reticulum stress. Hence, the current review aims at elucidating the mechanisms of the unfolded protein response and its regulation for improving MSCs viability. Lay Summary A major roadblock for successful use of adult stem cells in practice is their poor survivability once introduced in the patient's body. The stem cells tend to die quickly due to stress caused by activation of the unfolded protein response (UPR) pathway. Hence if we can target this UPR pathway (de-activation), then the cells might be able to survive for longer period of time that can help in regeneration of the desired tissue in our body. Future Works Future work can focus on designing therapies that can specifically inhibit UPR activation in stem cells pre and post transplantation such that they are able to survive and help in the desired tissue regeneration inside our body.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 50 条
  • [31] Complementary Cell-Based High-Throughput Screens Identify Novel Modulators of the Unfolded Protein Response
    Fribley, Andrew M.
    Cruz, Patricia G.
    Miller, Justin R.
    Callaghan, Michael U.
    Cai, Peter
    Narula, Neha
    Neubig, Richard R.
    Showalter, Hollis D.
    Larsen, Scott D.
    Kirchhoff, Paul D.
    Larsen, Martha J.
    Burr, Douglas A.
    Schultz, Pamela J.
    Jacobs, Renju R.
    Tamayo-Castillo, Giselle
    Ron, David
    Sherman, David H.
    Kaufman, Randal J.
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2011, 16 (08) : 825 - 835
  • [32] Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease
    Lai, Ruenn Chai
    Chen, Tian Sheng
    Lim, Sai Kiang
    [J]. REGENERATIVE MEDICINE, 2011, 6 (04) : 481 - 492
  • [33] Application of Nanomaterials in Stem Cell-Based Therapeutics for Cardiac Repair and Regeneration
    Qiu, Jie
    Liu, Xiang-Ju
    You, Bei-An
    Ren, Na
    Liu, Hong
    [J]. SMALL, 2023, 19 (11)
  • [34] Gene- and stem cell-based therapeutics for cartilage regeneration and repair
    Tang, Ying
    Wang, Bing
    [J]. STEM CELL RESEARCH & THERAPY, 2015, 6
  • [35] Gene- and stem cell-based therapeutics for cartilage regeneration and repair
    Ying Tang
    Bing Wang
    [J]. Stem Cell Research & Therapy, 6
  • [36] Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
    Zhang, Ximei
    Huang, Feng
    Chen, Yanming
    Qian, Xiaoxian
    Zheng, Song Guo
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (10): : 4017 - 4024
  • [37] Apoptosis: A friend or foe in mesenchymal stem cell-based immunosuppression
    Harrell, Carl Randall
    Volarevic, Vladislav
    [J]. APOPTOSIS IN HEALTH AND DISEASE, PT B, 2021, 126 : 39 - 62
  • [38] Osteoporosis: the current status of mesenchymal stem cell-based therapy
    Phetfong, Jitrada
    Sanvoranart, Tanwarat
    Nartprayut, Kuneerat
    Nimsanor, Natakarn
    Seenprachawong, Kanokwan
    Prachayasittikul, Virapong
    Supokawej, Aungkura
    [J]. CELLULAR & MOLECULAR BIOLOGY LETTERS, 2016, 21
  • [39] Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis
    Qi, Yiying
    Feng, Gang
    Yan, Weiqi
    [J]. MOLECULAR BIOLOGY REPORTS, 2012, 39 (05) : 5683 - 5689
  • [40] Update on mesenchymal stem cell-based therapy in lupus and scleroderma
    Cras, Audrey
    Farge, Dominique
    Carmoi, Thierry
    Lataillade, Jean-Jacques
    Wang, Dan Dan
    Sun, Lingyun
    [J]. ARTHRITIS RESEARCH & THERAPY, 2015, 17